K-pop

AKMU’s Lee Soo-hyun Sings on Remake of Seiko Matsuda’s “Blue Coral Reef”

New Entrant to the 'J-Pop Remake' Project… to Be Unveiled on the 18th

KIM HYUNSIK
2026-08-12 09:37:12
[Edaily Starin KIM HYUNSIK Reporter] Lee Soo-hyun of the duo AKMU is set to take the stage as the third vocalist in the “J-Pop Remake” project.
(Photo courtesy of SH Gold Networks)
(Photo courtesy of SH Gold Networks)
According to music production company
SH Gold Networks
on the 12th, the third track from the “J-Pop Remake” project, “Blue Coral Reef,” performed by Lee Soo-hyun, will be released at 6:00 p.m. on the 18th via various online music platforms.
“Blue Coral Reef” is a reinterpretation of the hit song of the same name released by Seiko Matsuda in 1980.
Lee Soo-hyun, beloved for her clear voice and delicate emotional expression, has reinterpreted the song—which blends a refreshing melody with lyrics capturing the flutter of youthful love—in her own unique style.
The “J-Pop Remake” project is a music initiative in which K-Pop artists reinterpret and perform classic J-Pop songs. Singer and TV personality Gangnam serves as the project’s producer, and a key feature is the adaptation of the original lyrics into Korean. Previously, Taeyeon and Han Roro performed remakes of Tsuki’s “Banquet Song” and Yoko Takahashi’s “The Thesis of the Cruel Angel,” respectively.

Economy

Corporation

IT·Science

Economy

"Aftermath of the Jensen Huang Scandal… U.S. to Impose Strict Export Controls on China"

“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
2026-11-13 17:31:12

Corporation

Shinwon Reports Improved Third-Quarter Earnings on the Back of Strong Exports

Fashion company Shinwon(009270)continues to show improved performance, driven by strong exports. This is attributed to the company’s expansion of its production and sales infrastructure, particularly …
2026-11-13 19:00:02

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02